ibandronic acid
SpainDrugs containing this active substance
-
It is used in adults with breast cancer that has spread to the bones (bone metastases) to help prevent fractures and other bone problems that might require surgery or radiotherapy.
Form: tablets, film-coated
Active substance Dosage ibandronic acid 50 mg Manufacturer: Atnahs Pharma Netherlands Bv.
-
It is used to treat postmenopausal osteoporosis in women at high risk of fractures. It helps to reverse bone loss and increase bone mass, which can reduce the probability of suffering vertebral fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid 150 mg Manufacturer: Atnahs Pharma Netherlands Bv.
-
It is used to treat postmenopausal osteoporosis in women at high risk of fractures, helping to reverse bone loss and reduce the risk of vertebral fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid 150 mg Manufacturer: Teva Pharma S.L.U.
-
It is used to treat postmenopausal osteoporosis in women at high risk of fractures. It helps prevent bone loss and can reduce the risk of vertebral fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid 150,00 mg Manufacturer: Laboratorios Alter S.A.
-
It is used to treat postmenopausal osteoporosis in women at high risk of fractures. It helps reverse bone loss and increase bone mass, which can reduce the probability of suffering vertebral fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid 150 mg Manufacturer: Laboratorios Cinfa S.A.
-
It is prescribed to treat osteoporosis in people at high risk of fractures. It helps prevent bone loss and increase bone mass, which reduces the probability of suffering vertebral fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid 150 mg Manufacturer: Kern Pharma S.L.
-
It is used to treat postmenopausal osteoporosis in women at high risk of fractures, helping to reverse bone loss and reduce the risk of vertebral fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid 150 mg Manufacturer: Laboratorios Normon S.A.
-
It is used to treat postmenopausal osteoporosis in women at high risk of fractures. It helps prevent bone loss and increase bone mass, which reduces the probability of suffering vertebral fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid 168,79 mg Manufacturer: Neuraxpharm Spain S.L.U.
-
It is used to treat postmenopausal osteoporosis in women at high risk of fractures. It helps prevent bone loss and can increase bone mass.
Form: tablets, film-coated
Active substance Dosage ibandronic acid 150 mg Manufacturer: Sandoz Farmaceutica S.A.
-
It is used to treat postmenopausal osteoporosis in women at high risk of fractures. It helps prevent bone loss and can increase bone mass, which helps reduce vertebral fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid 150 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to treat postmenopausal osteoporosis in women at high risk of fractures, helping to prevent bone loss and reduce the risk of vertebral fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid 150 mg Manufacturer: Tarbis Farma S.L.
-
It is used to treat postmenopausal osteoporosis in women at high risk of fractures. It helps prevent bone loss and can reduce the risk of vertebral fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid 150 mg Manufacturer: Tecnimede Espana Industria Farmaceutica S.A.
-
It is used to treat postmenopausal osteoporosis in women at high risk of fractures. It helps prevent bone loss and can reduce the risk of vertebral fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid 150 mg Manufacturer: Viatris Limited
-
It is used to treat postmenopausal osteoporosis in women at high risk of fractures. It helps prevent bone loss and can reduce the risk of vertebral fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid 150 mg Manufacturer: Industria Quimica Y Farmaceutica Vir S.A.